News
Xention Announces Attendance at Three Upcoming Conferences
14 September 2009
Xention is pleased to announce that it will be presenting at three investor and partnering conferences over the coming weeks.
Xention Limited Receives Wellcome Trust Award For Atrial Fibrillation Programme
6 July 2009
Xention has announced that it has received a substantial award from the Wellcome Trust (“Wellcome”) to support pioneering work on an exciting target for atrial fibrillation.
Xention Limited Builds Team with Appointment of Chief Medical Officer
8 June 2009
Xention has announced the appointment of Dr Patrick Round as Chief Medical Officer and Head of Development.
Xention Limited Strengthens Team with New Director of Business Development
19 May 2009
Xention has announced the appointment of Dr Calum Graham as Director of Business Development.
Xention Enters Drug Discovery Agreement with Ono Pharmaceutical Co., Ltd.
12 March 2009
Xention has announced that it has signed a Drug Discovery Agreement with Ono Pharmaceutical Co., Ltd. of Osaka, Japan (“Ono”).
Xention Limited Appoints Dr Keith McCullagh as New Chairman of its Board
2 February 2009
Xention has announced the appointment of Dr Keith McCullagh as the new non-executive Chairman of its Board of Directors.